Senior insider sale
Sr. VP of Clinical Development at SOLENO THERAPEUTICS INC — senior position signals high conviction
$1.48M
29.63K shares
What this filing means
HUANG MICHAEL F. plans to sell 29.63K shares of SOLENO THERAPEUTICS INC valued at approximately $1.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/27/2025ACC: 0001415889-25-009078
Officer· Sr. VP of Clinical Development
Since Apr 2024
29.63K
Shares to sell
$1.48M
Approx. market value
29.63K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Stock option exercises
Cash
3/27/2025
20KVesting of Restricted Stock Units - See Remarks
Equity Compensation
3/26/2025
9.63KTotal acquired29.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/27/2025 | Stock option exercises Cash | 20K | — |
3/26/2025 | Vesting of Restricted Stock Units - See Remarks Equity Compensation | 9.63K | — |
| Total | 29.63K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
29.63K
Market value
$1.48M
3/27/2025
Total
Units
29.63K
Value
$1.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/27/2025 | 29.63K | $1.48M | NASDAQ | Planned |
| Total | 29.63K | $1.48M | ||